Literature DB >> 19339752

Perceptual characteristics of Parkinsonian speech: a comparison of the pharmacological effects of levodopa across speech and non-speech motor systems.

E K Plowman-Prine1, M S Okun, C M Sapienza, R Shrivastav, H H Fernandez, K D Foote, C Ellis, A D Rodriguez, L M Burkhead, J C Rosenbek.   

Abstract

The purpose of this study was to: (1) define perceptual speech characteristics of idiopathic Parkinson disease (IPD) across 35 speech dimensions adapted from Darley et al. [19] and grouped under six speech-sign clusters (respiration, phonation, resonance, articulation, prosody and rate); (2) examine the effects of levodopa on the 35 perceptual speech dimensions and speech-sign clusters; and (3) to compare the relative effectiveness of levodopa on global motor functioning vs. speech production. Sixteen patients with IPD read the 'Grandfather Passage' both 'on' and 'off' levodopa. Three blinded speech-language pathologists performed perceptual speech analyses using a seven-point scale. The diagnosis of IPD was made by a movement disorders fellowship trained neurologist who applied UK Brain bank criteria and administered the Unified Parkinson Disease Rating Scale. Concordant with previous studies, the results of this experiment indicated that IPD disrupted multiple speech production subsystems, with prosody being the most severely affected domain. The perceptual dimensions that were most severely affected included: (1) sound imprecision; (2) mono-loudness; (3) mono-pitch; (4) reduced stress and (5) harsh voice. No significant differences were obtained between medicated states ('on'/'off') for any of the 35 individual speech dimensions and speech-sign clusters. Global motor function significantly improved following dopaminergic medications.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19339752     DOI: 10.3233/NRE-2009-0462

Source DB:  PubMed          Journal:  NeuroRehabilitation        ISSN: 1053-8135            Impact factor:   2.138


  33 in total

1.  Treatment of dysarthria following subthalamic nucleus deep brain stimulation for Parkinson's disease.

Authors:  Elina Tripoliti; Laura Strong; Freya Hickey; Tom Foltynie; Ludvic Zrinzo; Joseph Candelario; Marwan Hariz; Patricia Limousin
Journal:  Mov Disord       Date:  2011-09-27       Impact factor: 10.338

2.  Basic parameters of articulatory movements and acoustics in individuals with Parkinson's disease.

Authors:  Bridget Walsh; Anne Smith
Journal:  Mov Disord       Date:  2012-01-04       Impact factor: 10.338

Review 3.  Behavioral and neurophysiological correlates of striatal dopamine depletion: a rodent model of Parkinson's disease.

Authors:  Emily K Plowman; Jeffrey A Kleim
Journal:  J Commun Disord       Date:  2011-04-30       Impact factor: 2.288

4.  The Effect of SPEAK OUT! and The LOUD Crowd on Dysarthria Due to Parkinson's Disease.

Authors:  Alison Behrman; Jennifer Cody; Samantha Elandary; Peter Flom; Shilpa Chitnis
Journal:  Am J Speech Lang Pathol       Date:  2020-05-18       Impact factor: 2.408

5.  Quantitative Analysis of Catecholamines in the Pink1 -/- Rat Model of Early-onset Parkinson's Disease.

Authors:  Cynthia A Kelm-Nelson; Michael A Trevino; Michelle R Ciucci
Journal:  Neuroscience       Date:  2018-02-27       Impact factor: 3.590

6.  Listener Perception of Monopitch, Naturalness, and Intelligibility for Speakers With Parkinson's Disease.

Authors:  Supraja Anand; Cara E Stepp
Journal:  J Speech Lang Hear Res       Date:  2015-08       Impact factor: 2.297

7.  Noradrenergic receptor modulation influences the acoustic parameters of pro-social rat ultrasonic vocalizations.

Authors:  Laura M Grant; Kelsey J Barth; Cagla Muslu; Cynthia A Kelm-Nelson; Vaishali P Bakshi; Michelle R Ciucci
Journal:  Behav Neurosci       Date:  2018-07-09       Impact factor: 1.912

8.  Differential sensitivity of cranial and limb motor function to nigrostriatal dopamine depletion.

Authors:  Emily K Plowman; Nicholas Maling; Benjamin J Rivera; Krista Larson; Nagheme J Thomas; Stephen C Fowler; Fredric P Manfredsson; Rahul Shrivastav; Jeffrey A Kleim
Journal:  Behav Brain Res       Date:  2012-09-24       Impact factor: 3.332

9.  Vocalization deficits in mice over-expressing alpha-synuclein, a model of pre-manifest Parkinson's disease.

Authors:  Laura M Grant; Franziska Richter; Julie E Miller; Stephanie A White; Cynthia M Fox; Chunni Zhu; Marie-Francoise Chesselet; Michelle R Ciucci
Journal:  Behav Neurosci       Date:  2014-04       Impact factor: 1.912

10.  Effects of dopamine D1 and D2 receptor antagonists on laryngeal neurophysiology in the rat.

Authors:  Xin Feng; Victor M Henriquez; Judith R Walters; Christy L Ludlow
Journal:  J Neurophysiol       Date:  2009-06-17       Impact factor: 2.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.